|
1 Indications And Usage Anagrelide Is A Platelet Reducing Agent Indicated For The Treatment Of Thrombocythemia, Secondary To Myeloproliferative Neoplasms, To Reduce The Elevated Platelet Count And The Risk Of Thrombosis And To Ameliorate Associated Symptoms Including Thrombo-Hemorrhagic Events. ( 1 ) Anagrelide Capsules Are Indicated For The Treatment Of Patients With Thrombocythemia, Secondary To Myeloproliferative Neoplasms, To Reduce The Elevated Platelet Count And The Risk Of Thrombosis And To Ameliorate Associated Symptoms Including Thrombo-Hemorrhagic Events .
|